Adapting to hormone-therapy resistance for adopting the right therapeutic strategy in advanced prostate cancer

Giacomo Nuvola1, Matteo Santoni2, Mimma Rizzo3

  • 1Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italia.

Abstract

Insights

Understanding resistance to hormone therapy (HT) in prostate cancer (PCa) is crucial. This review details androgen receptor (AR) dependent and independent mechanisms driving treatment failure in PCa.

Area of Science:

  • Oncology
  • Molecular Biology
  • Urology

Background:

  • The androgen/androgen receptor (AR) axis is central to prostate cancer (PCa) progression and a primary cause of treatment resistance.
  • Androgen deprivation therapy (ADT) and targeted agents are standard treatments, but resistance limits their efficacy.

Approach:

  • This review synthesizes current data and emerging evidence on resistance mechanisms to hormone therapy (HT) in PCa.
  • Focus is placed on both primary and secondary resistance pathways.

Key Points:

  • Resistance mechanisms include AR gene amplification, somatic AR mutations, and intratumoral androgen synthesis.
  • Both AR-dependent and AR-independent pathways contribute to treatment failure.
  • Novel therapeutic strategies are required to overcome resistance.

Conclusions:

  • A comprehensive understanding of resistance mechanisms is fundamental for developing effective therapeutic strategies.
  • Personalized anticancer therapies are needed to improve outcomes for patients with HT-resistant PCa.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K